Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-09-08 Sale | 2026-09-09 4:02 pm | Artiva Biotherapeutics Inc. | ARTV | Aslan Fred Chief Executive Officer | 23,429 | $10.92 | $255,746 | 1,449,765 (Direct) | View |
| 2026-09-03 Sale | 2026-09-04 4:04 pm | Artiva Biotherapeutics Inc. | ARTV | Horan Christopher Chief Tech Operations Officer | 10,366 | $11.16 | $115,638 | 283,084 (Direct) | View |
| 2026-09-03 Sale | 2026-09-04 4:03 pm | Artiva Biotherapeutics Inc. | ARTV | Bush Jennifer COO, CLO, Compliance Officer | 8,391 | $11.16 | $93,606 | 329,529 (Direct) | View |
| 2026-09-03 Sale | 2026-09-04 4:03 pm | Artiva Biotherapeutics Inc. | ARTV | Banerjee Subhashis Chief Medical Officer | 1,100 | $11.16 | $12,271 | 140,947 (Direct) | View |
| 2026-09-03 Sale | 2026-09-04 4:02 pm | Artiva Biotherapeutics Inc. | ARTV | Aslan Fred Chief Executive Officer | 61,888 | $11.16 | $690,392 | 1,473,194 (Direct) | View |
| 2026-08-27 Sale | 2026-08-31 7:06 pm | Artiva Biotherapeutics Inc. | ARTV | Banerjee Subhashis Chief Medical Officer | 8,222 | $12.01 | $98,736 | 216,312 (Direct) | View |
| 2026-08-18 Sale | 2026-08-19 9:00 pm | Artiva Biotherapeutics Inc. | ARTV | Banerjee Subhashis Chief Medical Officer | 429 | $12 | $5,148 | 224,534 (Direct) | View |
| 2026-07-29 Purchase | 2026-07-31 5:13 pm | Artiva Biotherapeutics Inc. | ARTV | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund L.P. RA Capital Nexus Fund III L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner | 45,768 | $9.9573 | $455,726 | 18,489,293 (Indirect) | View |
| 2026-07-24 Purchase | 2026-07-28 5:24 pm | Artiva Biotherapeutics Inc. | ARTV | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund L.P. RA Capital Nexus Fund III L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner | 41,319 | $9.99 | $412,777 | 18,443,525 (Indirect) | View |
| 2026-07-21 Purchase | 2026-07-23 9:22 pm | Artiva Biotherapeutics Inc. | ARTV | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund L.P. RA Capital Nexus Fund III L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner | 264,586 | $9.7636 | $2,583,314 | 18,402,206 (Indirect) | View |
| 2026-07-13 Purchase(A) | 2026-07-23 9:21 pm | Artiva Biotherapeutics Inc. | ARTV | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund L.P. RA Capital Nexus Fund III L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner | 6,522 | $8.94 | $58,307 | 16,817,543 (Indirect) | View |
| 2026-07-16 Purchase | 2026-07-20 6:08 pm | Artiva Biotherapeutics Inc. | ARTV | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund L.P. RA Capital Nexus Fund III L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner | 160,354 | $8.931 | $1,432,119 | 18,137,650 (Indirect) | View |
| 2026-07-10 Purchase | 2026-07-14 7:00 pm | Artiva Biotherapeutics Inc. | ARTV | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund L.P. RA Capital Nexus Fund III L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner | 21,654 | $8.9609 | $194,040 | 17,977,296 (Indirect) | View |
| 2026-06-25 Purchase | 2026-06-29 4:20 pm | Artiva Biotherapeutics Inc. | ARTV | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund L.P. RA Capital Nexus Fund III L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner | 32,876 | $8.8857 | $292,126 | 17,955,642 (Indirect) | View |
| 2026-06-12 Purchase | 2026-06-16 6:08 pm | Artiva Biotherapeutics Inc. | ARTV | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund L.P. RA Capital Nexus Fund III L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner | 531,326 | $8.6574 | $4,599,903 | 17,922,766 (Indirect) | View |
| 2026-06-09 Purchase | 2026-06-11 7:36 pm | Artiva Biotherapeutics Inc. | ARTV | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund L.P. RA Capital Nexus Fund III L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner | 1,027,722 | $7.4438 | $7,650,148 | 17,391,440 (Indirect) | View |
| 2026-05-11 Purchase | 2026-05-28 4:34 pm | Artiva Biotherapeutics Inc. | ARTV | GC Corp. GC Cell Corp 10% Owner | 1,432,291 | $11.52 | $16,499,992 | 5,999,703 (Indirect Direct) | View |
| 2026-05-19 Sale | 2026-05-19 9:52 pm | Artiva Biotherapeutics Inc. | ARTV | Raymon Heather SVP, Research and Development | 3,095 | $9.0078 | $27,879 | 148,228 (Direct) | View |
| 2026-05-19 Sale | 2026-05-19 9:52 pm | Artiva Biotherapeutics Inc. | ARTV | Horan Christopher Chief Tech Operations Officer | 7,002 | $9.0078 | $63,073 | 293,450 (Direct) | View |
| 2026-05-19 Sale | 2026-05-19 9:51 pm | Artiva Biotherapeutics Inc. | ARTV | Bush Jennifer COO, CLO, Compliance Officer | 8,790 | $9.0078 | $79,179 | 337,920 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-09-15 Option Award | 2026-09-15 4:44 pm | N/A 2036-09-14 | Artiva Biotherapeutics Inc. | ARTV | Aslan Fred Chief Executive Officer | 425,000 | $0 | 1,919,765 (Direct) | View |
| 2026-09-10 Option Award | 2026-09-14 8:07 pm | N/A 2036-09-09 | Artiva Biotherapeutics Inc. | ARTV | Aslan Fred Chief Executive Officer | 200,000 | $0 | 1,649,765 (Direct) | View |
| 2026-09-10 Option Award | 2026-09-14 6:46 pm | N/A 2036-09-09 | Artiva Biotherapeutics Inc. | ARTV | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund L.P. RA Capital Nexus Fund III L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner | 16,250 | $0 | 16,250 (Indirect) | View |
| 2026-09-10 Option Award | 2026-09-14 4:05 pm | N/A 2036-09-09 | Artiva Biotherapeutics Inc. | ARTV | Stoppel Laura Director | 16,250 | $0 | 16,250 (Direct) | View |
| 2026-09-10 Option Award | 2026-09-14 4:04 pm | N/A 2036-09-09 | Artiva Biotherapeutics Inc. | ARTV | Sorg Elaine K. Director | 16,250 | $0 | 16,250 (Direct) | View |
| 2026-09-10 Option Award | 2026-09-14 4:04 pm | N/A 2036-09-09 | Artiva Biotherapeutics Inc. | ARTV | HOUGEN ELIZABETH L Director | 16,250 | $0 | 16,250 (Direct) | View |
| 2026-09-10 Option Award | 2026-09-14 4:03 pm | N/A 2036-09-09 | Artiva Biotherapeutics Inc. | ARTV | DANIELS BRIAN Director | 16,250 | $0 | 16,250 (Direct) | View |
| 2026-09-10 Option Award | 2026-09-14 4:03 pm | N/A 2036-09-09 | Artiva Biotherapeutics Inc. | ARTV | Baker Daniel G. Director | 16,250 | $0 | 16,250 (Direct) | View |
| 2026-09-10 Option Award | 2026-09-14 4:02 pm | N/A 2036-09-09 | Artiva Biotherapeutics Inc. | ARTV | MOORE ALISON Director | 16,250 | $0 | 16,250 (Direct) | View |
| 2026-09-09 Option Award | 2026-09-11 6:37 pm | N/A 2036-09-08 | Artiva Biotherapeutics Inc. | ARTV | Miralles Gines Diego President & Head of R&D | 180,000 | $0 | 257,500 (Direct) | View |
| 2026-09-09 Option Award | 2026-09-11 6:36 pm | N/A 2036-09-08 | Artiva Biotherapeutics Inc. | ARTV | Horan Christopher Chief Tech Operations Officer | 160,000 | $0 | 443,084 (Direct) | View |
| 2026-09-09 Option Award | 2026-09-11 6:36 pm | N/A 2036-09-08 | Artiva Biotherapeutics Inc. | ARTV | Bush Jennifer COO, CLO, Compliance Officer | 180,000 | $0 | 509,529 (Direct) | View |
| 2026-09-09 Option Award | 2026-09-11 6:35 pm | N/A 2036-09-08 | Artiva Biotherapeutics Inc. | ARTV | Banerjee Subhashis Chief Medical Officer | 115,000 | $0 | 255,947 (Direct) | View |
| 2026-09-08 Option Award | 2026-09-08 6:29 pm | N/A 2036-09-07 | Artiva Biotherapeutics Inc. | ARTV | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund L.P. RA Capital Nexus Fund III L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner | 13,750 | $0 | 13,750 (Indirect) | View |
| 2026-09-08 Option Award | 2026-09-08 5:58 pm | N/A 2036-09-07 | Artiva Biotherapeutics Inc. | ARTV | Stoppel Laura Director | 13,750 | $0 | 13,750 (Direct) | View |
| 2026-09-08 Option Award | 2026-09-08 5:57 pm | N/A 2036-09-07 | Artiva Biotherapeutics Inc. | ARTV | Sorg Elaine K. Director | 13,750 | $0 | 13,750 (Direct) | View |
| 2026-09-08 Option Award | 2026-09-08 5:56 pm | N/A 2036-09-07 | Artiva Biotherapeutics Inc. | ARTV | HOUGEN ELIZABETH L Director | 13,750 | $0 | 13,750 (Direct) | View |
| 2026-09-08 Option Award | 2026-09-08 5:56 pm | N/A 2036-09-07 | Artiva Biotherapeutics Inc. | ARTV | DANIELS BRIAN Director | 13,750 | $0 | 13,750 (Direct) | View |
| 2026-09-08 Option Award | 2026-09-08 5:55 pm | N/A 2036-09-07 | Artiva Biotherapeutics Inc. | ARTV | Baker Daniel G. Director | 13,750 | $0 | 13,750 (Direct) | View |
| 2026-09-08 Option Award | 2026-09-08 5:55 pm | N/A 2036-09-07 | Artiva Biotherapeutics Inc. | ARTV | MOORE ALISON Director | 13,750 | $0 | 13,750 (Direct) | View |
| 2026-08-27 Exercise | 2026-08-31 7:06 pm | N/A 2035-04-07 | Artiva Biotherapeutics Inc. | ARTV | Banerjee Subhashis Chief Medical Officer | 5,306 | $0 | 216,312 (Direct) | View |
| 2026-08-27 Exercise | 2026-08-31 7:06 pm | N/A N/A | Artiva Biotherapeutics Inc. | ARTV | Banerjee Subhashis Chief Medical Officer | 5,306 | $1.92 | 216,312 (Direct) | View |
| 2026-08-18 Exercise | 2026-08-19 9:00 pm | N/A 2035-04-07 | Artiva Biotherapeutics Inc. | ARTV | Banerjee Subhashis Chief Medical Officer | 429 | $0 | 224,534 (Direct) | View |
| 2026-08-18 Exercise | 2026-08-19 9:00 pm | N/A N/A | Artiva Biotherapeutics Inc. | ARTV | Banerjee Subhashis Chief Medical Officer | 429 | $1.92 | 224,534 (Direct) | View |